143 related articles for article (PubMed ID: 20980916)
1. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Delgado C; Song S; Hintze T; Cachofeiro V; Lahera V
J Cardiovasc Pharmacol; 2011 Jan; 57(1):114-21. PubMed ID: 20980916
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V
Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of proanthocyanidins in the cardiac alterations induced by aldosterone in rat heart through mineralocorticoid receptor blockade.
Martín-Fernández B; de las Heras N; Valero-Muñoz M; Ballesteros S; Yao YZ; Stanton PG; Fuller PJ; Lahera V
PLoS One; 2014; 9(10):e111104. PubMed ID: 25353961
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats.
Nakano S; Kobayashi N; Yoshida K; Ohno T; Matsuoka H
Hypertens Res; 2005 Nov; 28(11):925-36. PubMed ID: 16555582
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats.
Martín-Fernández B; Rubio-Navarro A; Cortegano I; Ballesteros S; Alía M; Cannata-Ortiz P; Olivares-Álvaro E; Egido J; de Andrés B; Gaspar ML; de Las Heras N; Lahera V; Moreno JA
PLoS One; 2016; 11(1):e0145946. PubMed ID: 26730742
[TBL] [Abstract][Full Text] [Related]
6. Relevance of SGK1 in structural, functional and molecular alterations produced by aldosterone in heart.
Martín-Fernández B; Valero Muñoz M; de las Heras N; Ballesteros S; Lahera V
Horm Mol Biol Clin Investig; 2014 May; 18(2):53-61. PubMed ID: 25390002
[TBL] [Abstract][Full Text] [Related]
7. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
Lebrasseur NK; Duhaney TA; De Silva DS; Cui L; Ip PC; Joseph L; Sam F
Hypertension; 2007 Sep; 50(3):489-96. PubMed ID: 17606858
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
Virdis A; Neves MF; Amiri F; Viel E; Touyz RM; Schiffrin EL
Hypertension; 2002 Oct; 40(4):504-10. PubMed ID: 12364354
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts.
Kobayashi N; Yoshida K; Nakano S; Ohno T; Honda T; Tsubokou Y; Matsuoka H
Hypertension; 2006 Apr; 47(4):671-9. PubMed ID: 16505212
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Spironolactone on Markers of Myocardial Oxidative Status, Inflammation and Remodeling in Hyperthyroid Rats.
Mayyas FA; Aljohmani AI; Alzoubi KH
Curr Mol Pharmacol; 2020; 13(3):206-215. PubMed ID: 31729306
[TBL] [Abstract][Full Text] [Related]
13. SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment.
Vallon V; Wyatt AW; Klingel K; Huang DY; Hussain A; Berchtold S; Friedrich B; Grahammer F; Belaiba RS; Görlach A; Wulff P; Daut J; Dalton ND; Ross J; Flögel U; Schrader J; Osswald H; Kandolf R; Kuhl D; Lang F
J Mol Med (Berl); 2006 May; 84(5):396-404. PubMed ID: 16604333
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone-induced inflammation in the rat heart : role of oxidative stress.
Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT
Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
Hosoya K; Minakuchi H; Wakino S; Fujimura K; Hasegawa K; Komatsu M; Yoshifuji A; Futatsugi K; Shinozuka K; Washida N; Kanda T; Tokuyama H; Hayashi K; Itoh H
Kidney Int; 2015 Apr; 87(4):749-60. PubMed ID: 25337775
[TBL] [Abstract][Full Text] [Related]
16. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
[TBL] [Abstract][Full Text] [Related]
17. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
[TBL] [Abstract][Full Text] [Related]
18. Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone.
Lal A; Veinot JP; Leenen FH
Am J Hypertens; 2003 Apr; 16(4):319-23. PubMed ID: 12670750
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K
Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats.
Kitada K; Nakano D; Liu Y; Fujisawa Y; Hitomi H; Shibayama Y; Shibata H; Nagai Y; Mori H; Masaki T; Kobori H; Nishiyama A
PLoS One; 2012; 7(7):e41896. PubMed ID: 22911865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
